Global Radiology Drug Therapy Supply, Demand and Key Producers, 2023-2029

Page: 111

Published Date: 14 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Radiology Drug Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease.

This report studies the global Radiology Drug Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Radiology Drug Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radiology Drug Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Radiology Drug Therapy total market, 2018-2029, (USD Million)
Global Radiology Drug Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Radiology Drug Therapy total market, key domestic companies and share, (USD Million)
Global Radiology Drug Therapy revenue by player and market share 2018-2023, (USD Million)
Global Radiology Drug Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Radiology Drug Therapy total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Radiology Drug Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nihon Medi-Physics, ITM Isotopen Technologien München AG, Advanced Accelerator Applications, Telix Pharmaceuticals, GE Healthcare, Theragnostics Ltd., NuView Life Sciences, Jubilant Pharma Limited and Lantheus Holdings, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radiology Drug Therapy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Radiology Drug Therapy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Radiology Drug Therapy Market, Segmentation by Type
Oncology
Cardiology
Others

Global Radiology Drug Therapy Market, Segmentation by Application
Hospitals
Academic & Research Institutes
Others

Companies Profiled:
Nihon Medi-Physics
ITM Isotopen Technologien München AG
Advanced Accelerator Applications
Telix Pharmaceuticals
GE Healthcare
Theragnostics Ltd.
NuView Life Sciences
Jubilant Pharma Limited
Lantheus Holdings, Inc.
Curium Pharma
Bayer AG
Clarity Pharmaceuticals

Key Questions Answered
1. How big is the global Radiology Drug Therapy market?
2. What is the demand of the global Radiology Drug Therapy market?
3. What is the year over year growth of the global Radiology Drug Therapy market?
4. What is the total value of the global Radiology Drug Therapy market?
5. Who are the major players in the global Radiology Drug Therapy market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Radiology Drug Therapy Introduction
    1.2 World Radiology Drug Therapy Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Radiology Drug Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Radiology Drug Therapy Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Radiology Drug Therapy Market Size (2018-2029)
        1.3.3 China Radiology Drug Therapy Market Size (2018-2029)
        1.3.4 Europe Radiology Drug Therapy Market Size (2018-2029)
        1.3.5 Japan Radiology Drug Therapy Market Size (2018-2029)
        1.3.6 South Korea Radiology Drug Therapy Market Size (2018-2029)
        1.3.7 ASEAN Radiology Drug Therapy Market Size (2018-2029)
        1.3.8 India Radiology Drug Therapy Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Radiology Drug Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Radiology Drug Therapy Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Radiology Drug Therapy Consumption Value (2018-2029)
    2.2 World Radiology Drug Therapy Consumption Value by Region
        2.2.1 World Radiology Drug Therapy Consumption Value by Region (2018-2023)
        2.2.2 World Radiology Drug Therapy Consumption Value Forecast by Region (2024-2029)
    2.3 United States Radiology Drug Therapy Consumption Value (2018-2029)
    2.4 China Radiology Drug Therapy Consumption Value (2018-2029)
    2.5 Europe Radiology Drug Therapy Consumption Value (2018-2029)
    2.6 Japan Radiology Drug Therapy Consumption Value (2018-2029)
    2.7 South Korea Radiology Drug Therapy Consumption Value (2018-2029)
    2.8 ASEAN Radiology Drug Therapy Consumption Value (2018-2029)
    2.9 India Radiology Drug Therapy Consumption Value (2018-2029)

3 World Radiology Drug Therapy Companies Competitive Analysis
    3.1 World Radiology Drug Therapy Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Radiology Drug Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Radiology Drug Therapy in 2022
        3.2.3 Global Concentration Ratios (CR8) for Radiology Drug Therapy in 2022
    3.3 Radiology Drug Therapy Company Evaluation Quadrant
    3.4 Radiology Drug Therapy Market: Overall Company Footprint Analysis
        3.4.1 Radiology Drug Therapy Market: Region Footprint
        3.4.2 Radiology Drug Therapy Market: Company Product Type Footprint
        3.4.3 Radiology Drug Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Radiology Drug Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Radiology Drug Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Radiology Drug Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Radiology Drug Therapy Consumption Value Comparison
        4.2.1 United States VS China: Radiology Drug Therapy Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Radiology Drug Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Radiology Drug Therapy Companies and Market Share, 2018-2023
        4.3.1 United States Based Radiology Drug Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Radiology Drug Therapy Revenue, (2018-2023)
    4.4 China Based Companies Radiology Drug Therapy Revenue and Market Share, 2018-2023
        4.4.1 China Based Radiology Drug Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Radiology Drug Therapy Revenue, (2018-2023)
    4.5 Rest of World Based Radiology Drug Therapy Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Radiology Drug Therapy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Radiology Drug Therapy Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Radiology Drug Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Oncology
        5.2.2 Cardiology
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Radiology Drug Therapy Market Size by Type (2018-2023)
        5.3.2 World Radiology Drug Therapy Market Size by Type (2024-2029)
        5.3.3 World Radiology Drug Therapy Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Radiology Drug Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Academic & Research Institutes
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Radiology Drug Therapy Market Size by Application (2018-2023)
        6.3.2 World Radiology Drug Therapy Market Size by Application (2024-2029)
        6.3.3 World Radiology Drug Therapy Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Nihon Medi-Physics
        7.1.1 Nihon Medi-Physics Details
        7.1.2 Nihon Medi-Physics Major Business
        7.1.3 Nihon Medi-Physics Radiology Drug Therapy Product and Services
        7.1.4 Nihon Medi-Physics Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Nihon Medi-Physics Recent Developments/Updates
        7.1.6 Nihon Medi-Physics Competitive Strengths & Weaknesses
    7.2 ITM Isotopen Technologien München AG
        7.2.1 ITM Isotopen Technologien München AG Details
        7.2.2 ITM Isotopen Technologien München AG Major Business
        7.2.3 ITM Isotopen Technologien München AG Radiology Drug Therapy Product and Services
        7.2.4 ITM Isotopen Technologien München AG Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 ITM Isotopen Technologien München AG Recent Developments/Updates
        7.2.6 ITM Isotopen Technologien München AG Competitive Strengths & Weaknesses
    7.3 Advanced Accelerator Applications
        7.3.1 Advanced Accelerator Applications Details
        7.3.2 Advanced Accelerator Applications Major Business
        7.3.3 Advanced Accelerator Applications Radiology Drug Therapy Product and Services
        7.3.4 Advanced Accelerator Applications Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Advanced Accelerator Applications Recent Developments/Updates
        7.3.6 Advanced Accelerator Applications Competitive Strengths & Weaknesses
    7.4 Telix Pharmaceuticals
        7.4.1 Telix Pharmaceuticals Details
        7.4.2 Telix Pharmaceuticals Major Business
        7.4.3 Telix Pharmaceuticals Radiology Drug Therapy Product and Services
        7.4.4 Telix Pharmaceuticals Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Telix Pharmaceuticals Recent Developments/Updates
        7.4.6 Telix Pharmaceuticals Competitive Strengths & Weaknesses
    7.5 GE Healthcare
        7.5.1 GE Healthcare Details
        7.5.2 GE Healthcare Major Business
        7.5.3 GE Healthcare Radiology Drug Therapy Product and Services
        7.5.4 GE Healthcare Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 GE Healthcare Recent Developments/Updates
        7.5.6 GE Healthcare Competitive Strengths & Weaknesses
    7.6 Theragnostics Ltd.
        7.6.1 Theragnostics Ltd. Details
        7.6.2 Theragnostics Ltd. Major Business
        7.6.3 Theragnostics Ltd. Radiology Drug Therapy Product and Services
        7.6.4 Theragnostics Ltd. Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Theragnostics Ltd. Recent Developments/Updates
        7.6.6 Theragnostics Ltd. Competitive Strengths & Weaknesses
    7.7 NuView Life Sciences
        7.7.1 NuView Life Sciences Details
        7.7.2 NuView Life Sciences Major Business
        7.7.3 NuView Life Sciences Radiology Drug Therapy Product and Services
        7.7.4 NuView Life Sciences Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 NuView Life Sciences Recent Developments/Updates
        7.7.6 NuView Life Sciences Competitive Strengths & Weaknesses
    7.8 Jubilant Pharma Limited
        7.8.1 Jubilant Pharma Limited Details
        7.8.2 Jubilant Pharma Limited Major Business
        7.8.3 Jubilant Pharma Limited Radiology Drug Therapy Product and Services
        7.8.4 Jubilant Pharma Limited Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Jubilant Pharma Limited Recent Developments/Updates
        7.8.6 Jubilant Pharma Limited Competitive Strengths & Weaknesses
    7.9 Lantheus Holdings, Inc.
        7.9.1 Lantheus Holdings, Inc. Details
        7.9.2 Lantheus Holdings, Inc. Major Business
        7.9.3 Lantheus Holdings, Inc. Radiology Drug Therapy Product and Services
        7.9.4 Lantheus Holdings, Inc. Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Lantheus Holdings, Inc. Recent Developments/Updates
        7.9.6 Lantheus Holdings, Inc. Competitive Strengths & Weaknesses
    7.10 Curium Pharma
        7.10.1 Curium Pharma Details
        7.10.2 Curium Pharma Major Business
        7.10.3 Curium Pharma Radiology Drug Therapy Product and Services
        7.10.4 Curium Pharma Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Curium Pharma Recent Developments/Updates
        7.10.6 Curium Pharma Competitive Strengths & Weaknesses
    7.11 Bayer AG
        7.11.1 Bayer AG Details
        7.11.2 Bayer AG Major Business
        7.11.3 Bayer AG Radiology Drug Therapy Product and Services
        7.11.4 Bayer AG Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Bayer AG Recent Developments/Updates
        7.11.6 Bayer AG Competitive Strengths & Weaknesses
    7.12 Clarity Pharmaceuticals
        7.12.1 Clarity Pharmaceuticals Details
        7.12.2 Clarity Pharmaceuticals Major Business
        7.12.3 Clarity Pharmaceuticals Radiology Drug Therapy Product and Services
        7.12.4 Clarity Pharmaceuticals Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Clarity Pharmaceuticals Recent Developments/Updates
        7.12.6 Clarity Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Radiology Drug Therapy Industry Chain
    8.2 Radiology Drug Therapy Upstream Analysis
    8.3 Radiology Drug Therapy Midstream Analysis
    8.4 Radiology Drug Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Radiology Drug Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Radiology Drug Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Radiology Drug Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Radiology Drug Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Radiology Drug Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Radiology Drug Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Radiology Drug Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Radiology Drug Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Radiology Drug Therapy Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Radiology Drug Therapy Players in 2022
    Table 12. World Radiology Drug Therapy Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Radiology Drug Therapy Company Evaluation Quadrant
    Table 14. Head Office of Key Radiology Drug Therapy Player
    Table 15. Radiology Drug Therapy Market: Company Product Type Footprint
    Table 16. Radiology Drug Therapy Market: Company Product Application Footprint
    Table 17. Radiology Drug Therapy Mergers & Acquisitions Activity
    Table 18. United States VS China Radiology Drug Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Radiology Drug Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Radiology Drug Therapy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Radiology Drug Therapy Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Radiology Drug Therapy Revenue Market Share (2018-2023)
    Table 23. China Based Radiology Drug Therapy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Radiology Drug Therapy Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Radiology Drug Therapy Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Radiology Drug Therapy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Radiology Drug Therapy Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Radiology Drug Therapy Revenue Market Share (2018-2023)
    Table 29. World Radiology Drug Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Radiology Drug Therapy Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Radiology Drug Therapy Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Radiology Drug Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Radiology Drug Therapy Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Radiology Drug Therapy Market Size by Application (2024-2029) & (USD Million)
    Table 35. Nihon Medi-Physics Basic Information, Area Served and Competitors
    Table 36. Nihon Medi-Physics Major Business
    Table 37. Nihon Medi-Physics Radiology Drug Therapy Product and Services
    Table 38. Nihon Medi-Physics Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Nihon Medi-Physics Recent Developments/Updates
    Table 40. Nihon Medi-Physics Competitive Strengths & Weaknesses
    Table 41. ITM Isotopen Technologien München AG Basic Information, Area Served and Competitors
    Table 42. ITM Isotopen Technologien München AG Major Business
    Table 43. ITM Isotopen Technologien München AG Radiology Drug Therapy Product and Services
    Table 44. ITM Isotopen Technologien München AG Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. ITM Isotopen Technologien München AG Recent Developments/Updates
    Table 46. ITM Isotopen Technologien München AG Competitive Strengths & Weaknesses
    Table 47. Advanced Accelerator Applications Basic Information, Area Served and Competitors
    Table 48. Advanced Accelerator Applications Major Business
    Table 49. Advanced Accelerator Applications Radiology Drug Therapy Product and Services
    Table 50. Advanced Accelerator Applications Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Advanced Accelerator Applications Recent Developments/Updates
    Table 52. Advanced Accelerator Applications Competitive Strengths & Weaknesses
    Table 53. Telix Pharmaceuticals Basic Information, Area Served and Competitors
    Table 54. Telix Pharmaceuticals Major Business
    Table 55. Telix Pharmaceuticals Radiology Drug Therapy Product and Services
    Table 56. Telix Pharmaceuticals Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Telix Pharmaceuticals Recent Developments/Updates
    Table 58. Telix Pharmaceuticals Competitive Strengths & Weaknesses
    Table 59. GE Healthcare Basic Information, Area Served and Competitors
    Table 60. GE Healthcare Major Business
    Table 61. GE Healthcare Radiology Drug Therapy Product and Services
    Table 62. GE Healthcare Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. GE Healthcare Recent Developments/Updates
    Table 64. GE Healthcare Competitive Strengths & Weaknesses
    Table 65. Theragnostics Ltd. Basic Information, Area Served and Competitors
    Table 66. Theragnostics Ltd. Major Business
    Table 67. Theragnostics Ltd. Radiology Drug Therapy Product and Services
    Table 68. Theragnostics Ltd. Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Theragnostics Ltd. Recent Developments/Updates
    Table 70. Theragnostics Ltd. Competitive Strengths & Weaknesses
    Table 71. NuView Life Sciences Basic Information, Area Served and Competitors
    Table 72. NuView Life Sciences Major Business
    Table 73. NuView Life Sciences Radiology Drug Therapy Product and Services
    Table 74. NuView Life Sciences Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. NuView Life Sciences Recent Developments/Updates
    Table 76. NuView Life Sciences Competitive Strengths & Weaknesses
    Table 77. Jubilant Pharma Limited Basic Information, Area Served and Competitors
    Table 78. Jubilant Pharma Limited Major Business
    Table 79. Jubilant Pharma Limited Radiology Drug Therapy Product and Services
    Table 80. Jubilant Pharma Limited Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Jubilant Pharma Limited Recent Developments/Updates
    Table 82. Jubilant Pharma Limited Competitive Strengths & Weaknesses
    Table 83. Lantheus Holdings, Inc. Basic Information, Area Served and Competitors
    Table 84. Lantheus Holdings, Inc. Major Business
    Table 85. Lantheus Holdings, Inc. Radiology Drug Therapy Product and Services
    Table 86. Lantheus Holdings, Inc. Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Lantheus Holdings, Inc. Recent Developments/Updates
    Table 88. Lantheus Holdings, Inc. Competitive Strengths & Weaknesses
    Table 89. Curium Pharma Basic Information, Area Served and Competitors
    Table 90. Curium Pharma Major Business
    Table 91. Curium Pharma Radiology Drug Therapy Product and Services
    Table 92. Curium Pharma Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Curium Pharma Recent Developments/Updates
    Table 94. Curium Pharma Competitive Strengths & Weaknesses
    Table 95. Bayer AG Basic Information, Area Served and Competitors
    Table 96. Bayer AG Major Business
    Table 97. Bayer AG Radiology Drug Therapy Product and Services
    Table 98. Bayer AG Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Bayer AG Recent Developments/Updates
    Table 100. Clarity Pharmaceuticals Basic Information, Area Served and Competitors
    Table 101. Clarity Pharmaceuticals Major Business
    Table 102. Clarity Pharmaceuticals Radiology Drug Therapy Product and Services
    Table 103. Clarity Pharmaceuticals Radiology Drug Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 104. Global Key Players of Radiology Drug Therapy Upstream (Raw Materials)
    Table 105. Radiology Drug Therapy Typical Customers
List of Figure
    Figure 1. Radiology Drug Therapy Picture
    Figure 2. World Radiology Drug Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Radiology Drug Therapy Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Radiology Drug Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Radiology Drug Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Radiology Drug Therapy Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Radiology Drug Therapy Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Radiology Drug Therapy Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Radiology Drug Therapy Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Radiology Drug Therapy Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Radiology Drug Therapy Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Radiology Drug Therapy Revenue (2018-2029) & (USD Million)
    Figure 13. Radiology Drug Therapy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Radiology Drug Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Radiology Drug Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Radiology Drug Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Radiology Drug Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Radiology Drug Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Radiology Drug Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Radiology Drug Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Radiology Drug Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Radiology Drug Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Radiology Drug Therapy by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Radiology Drug Therapy Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Radiology Drug Therapy Markets in 2022
    Figure 27. United States VS China: Radiology Drug Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Radiology Drug Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Radiology Drug Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Radiology Drug Therapy Market Size Market Share by Type in 2022
    Figure 31. Oncology
    Figure 32. Cardiology
    Figure 33. Others
    Figure 34. World Radiology Drug Therapy Market Size Market Share by Type (2018-2029)
    Figure 35. World Radiology Drug Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Radiology Drug Therapy Market Size Market Share by Application in 2022
    Figure 37. Hospitals
    Figure 38. Academic & Research Institutes
    Figure 39. Others
    Figure 40. Radiology Drug Therapy Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Radiology Drug Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Radiology Drug Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 14 Mar 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Radiology Drug Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Radiology Drug Therapy Supply, Demand and Key Producers, 2024-2030

Global Radiology Drug Therapy Supply, Demand and Key Producers, 2024-2030

date 13 Feb 2024

date Pharma & Healthcare

The global Radiology Drug Therapy market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Radiology Drug Therapy

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>